No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs75363952 |
chr6:55038167-55038168 |
Inactive region
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs140926542 |
chr6:55038218-55038219 |
Inactive region
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs192661818 |
chr6:55038227-55038228 |
Inactive region
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs537094004 |
chr6:55038229-55038230 |
Inactive region
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs568481213 |
chr6:55038671-55038672 |
Inactive region
|
CpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs192524665 |
chr6:55038823-55038824 |
Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs553464120 |
chr6:55038856-55038857 |
Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs142553104 |
chr6:55038861-55038862 |
Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs199997961 |
chr6:55038947-55038948 |
Bivalent Enhancer Active TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs557492006 |
chr6:55038948-55038949 |
Bivalent Enhancer Active TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs9370397 |
chr6:55038955-55038956 |
Bivalent Enhancer Active TSS
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
12 |
rs572398930 |
chr6:55038961-55038962 |
Bivalent Enhancer Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs546068247 |
chr6:55038971-55038972 |
Bivalent Enhancer Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs558789864 |
chr6:55038985-55038986 |
Bivalent Enhancer Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs373995163 |
chr6:55038989-55038990 |
Bivalent Enhancer Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs80000222 |
chr6:55039002-55039003 |
Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs199944527 |
chr6:55039017-55039018 |
Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs200543011 |
chr6:55039027-55039028 |
Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs202048479 |
chr6:55039035-55039036 |
Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs200024843 |
chr6:55039036-55039037 |
Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs575571604 |
chr6:55039048-55039049 |
Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs201145687 |
chr6:55039064-55039065 |
Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs201943159 |
chr6:55039068-55039069 |
Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs199932130 |
chr6:55039069-55039070 |
Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs560693374 |
chr6:55039077-55039078 |
Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs201021145 |
chr6:55039091-55039092 |
Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs201824178 |
chr6:55039096-55039097 |
Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs200274655 |
chr6:55039097-55039098 |
Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs201035223 |
chr6:55039118-55039119 |
Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs529721189 |
chr6:55039140-55039141 |
Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs202235145 |
chr6:55039148-55039149 |
Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs576279924 |
chr6:55039152-55039153 |
Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs200428399 |
chr6:55039164-55039165 |
Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs201504442 |
chr6:55039182-55039183 |
Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs199634246 |
chr6:55039183-55039184 |
Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs200530669 |
chr6:55039185-55039186 |
Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs539937395 |
chr6:55039203-55039204 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs559857626 |
chr6:55039216-55039217 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs201539986 |
chr6:55039219-55039220 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs368148229 |
chr6:55039233-55039234 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs199702325 |
chr6:55039246-55039247 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs541721379 |
chr6:55039259-55039260 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs200608285 |
chr6:55039269-55039270 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs201629106 |
chr6:55039286-55039287 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs200162484 |
chr6:55039301-55039302 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs200907489 |
chr6:55039303-55039304 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs202041383 |
chr6:55039306-55039307 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs571522264 |
chr6:55039307-55039308 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs199991760 |
chr6:55039324-55039325 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs200775372 |
chr6:55039336-55039337 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|